U.S. Construction Stock News

In early August 2026, Willdan Group, Inc. reported second-quarter sales of US$231.03 million and net income of US$24.35 million, both higher than a year earlier, alongside record diluted earnings per share from continuing operations of US$1.58. Alongside these results, Willdan raised its 2026 financial targets, now aiming for full-year net revenue of US$415 million to US$430 million, supported by growing commercial and data center work and recent acquisitions. With record earnings and higher...

Crocs stock has delivered a strong 81.6% return over the past year, yet the latest valuation checks still point to the shares trading below an estimate of intrinsic value based on a Discounted Cash Flow (DCF) model and market multiples. The 81.6% gain over the last 12 months suggests sentiment around Crocs has been positive, even with recent swings around company updates. Recent record revenue and changes to how marketplace sales are reported can support cash flow expectations, while a...

Camden Property Trust (CPT) has reshaped its portfolio after completing the sale of its California assets for US$1.625b, redirecting capital toward newer Sunbelt properties, share repurchases, and reaffirmed full year guidance. See our latest analysis for Camden Property Trust. Camden Property Trust's latest California sale and Sunbelt repositioning come after a steady 6.68% 90 day share price return and a 10.40% 1 year total shareholder return. The 5 year total shareholder return shows a...

Intel (INTC) shares are back in focus after the company appointed Dean Jarnac as executive vice president and chief sales officer, putting a new leader in charge of its global sales engine. See our latest analysis for Intel. Intel's recent executive changes and partnerships, including the Terafab joint venture and new foundry customers, come as momentum has cooled in the short term. The 30-day share price return is down 7.46% and the 90-day share price return is down 21.47%, while the...

Lindsay stock reaction and recent performance snapshot Lindsay (LNN) shares recently traded around $116.06, with the stock up about 1.2% over the past day and 4.7% over the past week. Returns over the past month and past 3 months were also positive. See our latest analysis for Lindsay. Short term momentum in Lindsay's share price has picked up recently, with a 7 day share price return of 4.73% and a 90 day share price return of 6.61%. However, longer term total shareholder returns over 1, 3...

Stevanato Group S.p.A. recently reported past second-quarter 2026 results showing sales rising to €302 million from €280.04 million a year earlier, while net income decreased to €22.96 million and full-year 2026 guidance was slightly narrowed alongside confirming expectations for revenue of about €1.26–€1.28 billion and diluted EPS of €0.53–€0.55. A few days earlier, liraglutide-based combination products using Stevanato’s proprietary Alina variable-dose pen injector platform received...

CoreCivic recently completed the sale of four facilities, including two ICE detention centers sold to the U.S. government for an aggregate US$734.0 million, raised full-year 2026 earnings guidance to US$1.50–US$1.52 billion in net income and US$15.00–US$15.20 in diluted EPS, and used part of the proceeds to repay US$608.5 million of debt while expanding its share repurchase authorization to US$1.20 billion. Although these asset sales generate a very large accounting gain in 2026, CoreCivic...

Headlines about DPD and missed sick pay have turned the spotlight on how companies handle worker rights, compliance and payroll. That scrutiny could reshape which businesses clients trust with sensitive employment tasks. For investors, that raises the possibility that some compliance and employment services stocks may stand out. This article explains the story behind that shift and highlights 3 stocks exposed to this news event from our specialist screener. The three stocks in the article...

nVent Electric plc recently reported past second-quarter 2026 results showing sales rising to US$1,471.3 million and net income to US$215.9 million, alongside announcing a new 160,000 square-foot Blaine, Minnesota facility to expand data center liquid cooling capacity. A key insight is that this Blaine expansion marks nVent’s third data center liquid cooling capacity increase in three years, indicating a concentrated push to meet AI-driven infrastructure demand. We’ll now examine how nVent’s...

Bladex earnings and dividend decision set the stage for investors Bladex (BLX) stock is back in focus after the bank reported second quarter 2026 results alongside a new quarterly dividend decision, giving investors fresh numbers on profitability and cash returns. See our latest analysis for Bladex. The latest earnings and dividend news comes after a strong period for Bladex, with the share price up 30.05% year to date and a 1 year total shareholder return of 42.66%. The recent 1 month share...

Intercontinental Exchange (ICE) reported July 2026 operating metrics that show higher trading activity across its markets, with total average daily volume up 25% year on year and open interest up 18%. See our latest analysis for Intercontinental Exchange. The stronger July trading metrics arrive after a busy few weeks for Intercontinental Exchange, which included second quarter earnings, a higher quarterly dividend and ongoing share buybacks. Even with this backdrop, the stock’s recent 30 day...

Abercrombie & Fitch recently marked its Fall 2026 denim campaign with a New York event featuring style figures such as Paloma Elsesser and Emily Ratajkowski, underscoring the brand’s emphasis on fashion identity and urban roots. At the same time, investors are watching the company’s upcoming August 26, 2026 earnings release, with analyst expectations of higher revenue but lower earnings per share and a valuation that screens favorably against industry peers. Next, we will examine how...

Tecnoglass Holdings Inc. has already reported its second-quarter 2026 results, with record revenue of US$295.29 million but lower net income of US$24.56 million and diluted EPS of US$0.55 compared with the prior year, alongside narrowed full-year 2026 revenue guidance of US$1.08 billion to US$1.12 billion. Behind the headline revenue records, the company is contending with higher aluminum costs and Colombian peso strength, which, together with its recent U.S. redomiciliation and shifting...

Kodiak Sciences has completed enrollment of the first 300-patient cohort in its Phase 3 PEAK trial of KSI-101 for macular edema secondary to inflammation, advancing a bispecific IL-6/VEGF therapy through a pivotal analysis that will inform regulatory paths. An interesting aspect of this update is how PEAK and the complementary PINNACLE study are structured to span a broad spectrum of MESI severity, from mild to more advanced disease, potentially broadening the therapy’s clinical relevance if...

In early August 2026, Tarsus Pharmaceuticals reported second-quarter revenue of US$173.91 million and a net loss of US$18.55 million, while also raising full-year 2026 XDEMVY net product sales guidance to US$685 million–US$705 million. The earnings update highlighted strong XDEMVY uptake, with more than 700,000 patients treated since launch and an acquisition of Alkeus Pharmaceuticals to broaden Tarsus’ ophthalmology pipeline. We’ll now examine how this stronger XDEMVY sales outlook and...

Why Toast stock is back in focus Toast (TOST) is drawing fresh attention after announcing an expanded integration with Google for AI powered food ordering in Google Maps, alongside a new endorsement as a point of sale option by BWH Hotels. See our latest analysis for Toast. For context, Toast’s share price is US$34.48, with a 30 day share price return of 17.6% and a 90 day share price return of 42.54%, while the 1 year total shareholder return is down 19.96% and the 3 year total shareholder...

Solaris Energy Infrastructure, Inc. recently reported past second-quarter 2026 results showing sales of US$105.72 million and net income of US$20.49 million, alongside affirming a third-quarter dividend of US$0.12 per share, marking its 32nd consecutive payout. Despite year-on-year growth in revenue and net income for both the quarter and first half of 2026, diluted earnings per share from continuing operations eased slightly in the latest quarter, hinting at increased share count or mix...

In August 2026, BillionToOne, Inc. reported that second-quarter 2026 sales rose to US$109.45 million with net income of US$8.05 million, and reaffirmed its full-year 2026 revenue outlook of US$450.0 million to US$465.0 million compared with 2025. The shift from a small loss to positive earnings per share across both the quarter and first half highlights a meaningful improvement in profitability alongside rapid revenue expansion. We’ll now examine how BillionToOne’s strong shift to...

Kiniksa Pharmaceuticals International, plc recently reported its second-quarter 2026 results, with revenue of US$243.6 million and net income of US$25.43 million, and raised its full-year 2026 net product revenue guidance to a range of US$980 million to US$995 million from US$930 million to US$945 million. The combination of higher guidance and year-on-year growth in revenue and earnings per share highlights management’s increased confidence in the durability of the company’s current...

Event driven focus on Autodesk stock Autodesk (ADSK) is back in the spotlight after recent work on discounted cash flow valuation, the integration of MaintainX, and steady fiscal Q2 sales trends during restructuring, all ahead of the 27 August 2026 earnings release. See our latest analysis for Autodesk. Autodesk's recent news sits against a mixed share price backdrop, with a 19.49% 1 month share price return and 6.35% 7 day share price return, yet a year to date share price return that is...

Dyne Therapeutics (DYN) has drawn fresh investor attention after receiving U.S. Food and Drug Administration clearance to begin a Phase 1 trial of DYNE-302 for facioscapulohumeral muscular dystrophy, a rare muscle disease without approved treatments. See our latest analysis for Dyne Therapeutics. At a share price of $26.25, Dyne Therapeutics has seen strong recent momentum, with a 30 day share price return of 12.08% and a 1 year total shareholder return of 135.22%, which suggests investor...

Why Insmed Stock Is Back In Focus After Q2 Earnings Insmed (INSM) has moved back into the spotlight after second quarter 2026 earnings on 6 August. The company reported a sharply smaller net loss and raised its full year revenue guidance, which helped spark renewed investor interest. See our latest analysis for Insmed. Insmed’s recent earnings release and revenue guidance update have come after a strong 7 day share price return of 32.96% and a 90 day share price return of 26.19%. However, the...

Strategy stock has delivered a very large 3 year gain while the broader valuation checks still lean cautious. This leaves investors weighing a strong historical return against signals that the shares are not clearly cheap. Over the past 3 years Strategy has returned about 160%, which shows how powerful the move has been for long term holders despite deeper recent drawdowns. The key driver for how the stock is priced remains market confidence in Strategy's Bitcoin centric treasury model. At...

Callaway Golf stock has more than doubled over the past year, yet the valuation signals are pulling in different directions. The Discounted Cash Flow (DCF) intrinsic value estimate points to the shares trading below fair value, while earnings-based multiples and broader checks suggest the stock is not a clear bargain. Callaway Golf has delivered a 104.5% return over the past year, which puts extra focus on whether the current price still leaves room for upside. Stronger recent sales and...